AMH and Insulin resistance: Through the inclusion of detailed hormonal profiling including anti-Müllerian hormone (AMH) as a marker of ovarian reserve, thyroid-stimulating hormone (TSH) to assess thyroid axis activity, and the homeostatic model assessment of insulin resistance (HOMA-IR) to capture underlying metabolic dysfunction, this study offers a multidimensional view of the endocrine landscape in these patients.